Rochelle E. Nasto, Ph.D. - Publications

Affiliations: 
2014 Biomedical Engineering (School of Biomedical Engineering, Science, and Health Systems) Drexel University, Philadelphia, PA, United States 
Area:
Biomedical Engineering, Systematic Biology, Oncology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zhang YW, Nasto RE, Jablonski SA, Serebriiskii IG, Surana R, Murray J, Johnson M, Riggins RB, Clarke R, Golemis EA, Weiner LM. RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attack. Methods in Enzymology. 636: 299-322. PMID 32178823 DOI: 10.1016/Bs.Mie.2019.06.002  0.564
2017 Zhang YW, Nasto RE, Jablonski SA, Serebriiskii IG, Surana R, Murray J, Johnson M, Riggins RB, Clarke R, Golemis EA, Weiner LM. RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells. Bio-Protocol. 7. PMID 29250574 DOI: 10.21769/BioProtoc.2435  0.532
2015 Zhang YW, Nasto RE, Varghese R, Jablonski SA, Serebriiskii IG, Surana R, Calvert VS, Bebu I, Murray J, Jin L, Johnson M, Riggins R, Ressom H, Petricoin E, Clarke R, et al. Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation. Oncogene. PMID 26165839 DOI: 10.1038/Onc.2015.226  0.562
2015 Zhang Y, Nasto RE, Varghese R, Jablonski SA, Serebriiskii IG, Surana R, Calvert VS, Bebu I, Murray J, Jin L, Johnson M, Riggins R, Ressom H, Petricoin E, Clarke R, et al. Abstract 1716: Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation Cancer Research. 75: 1716-1716. DOI: 10.1158/1538-7445.Am2015-1716  0.559
2014 Murray JC, Aldeghaither D, Wang S, Nasto RE, Jablonski SA, Tang Y, Weiner LM. c-Abl modulates tumor cell sensitivity to antibody-dependent cellular cytotoxicity. Cancer Immunology Research. 2: 1186-98. PMID 25300860 DOI: 10.1158/2326-6066.Cir-14-0083  0.518
2013 Murray JC, Nasto RE, Jablonski SA, Tang Y, Weiner LM. Abstract 2847: Molecular determinants of sensitivity and resistance to tumor-directed antibody-dependent cellular cytotoxicity (ADCC). Cancer Research. 73: 2847-2847. DOI: 10.1158/1538-7445.Am2013-2847  0.535
2013 Zhang Y, Nasto R, Clarke R, Weiner LM. Abstract 2042: TOB1 promotes cell survival in estrogen-independent estrogen receptor-positive breast cancer. Cancer Research. 73: 2042-2042. DOI: 10.1158/1538-7445.Am2013-2042  0.564
2012 Murray JC, Nasto RE, Jablonski SA, Tang Y, Weiner LM. Abstract LB-128: Targeted RNAi screening of an EGFR network reveals molecular determinants of tumor cell sensitivity to antibody-dependent cellular cytotoxicity (ADCC) Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-128  0.555
2010 Astsaturov I, Ratushny V, Sukhanova A, Einarson MB, Bagnyukova T, Zhou Y, Devarajan K, Silverman JS, Tikhmyanova N, Skobeleva N, Pecherskaya A, Nasto RE, Sharma C, Jablonski SA, Serebriiskii IG, et al. Synthetic lethal screen of an EGFR-centered network to improve targeted therapies. Science Signaling. 3: ra67. PMID 20858866 DOI: 10.1126/Scisignal.2001083  0.498
2010 Nasto RE, Serebriiskii I, Jablonski SA, Johnson MD, Clarke R, Weiner LM, Golemis EA. Abstract 2014: An estrogen receptor - centered network for probing anti-estrogen drug resistance with siRNA screening technology Cancer Research. 70: 2014-2014. DOI: 10.1158/1538-7445.Am10-2014  0.553
2009 Hopper-Borge EA, Nasto RE, Ratushny V, Weiner LM, Golemis EA, Astsaturov I. Mechanisms of tumor resistance to EGFR-targeted therapies. Expert Opinion On Therapeutic Targets. 13: 339-62. PMID 19236156 DOI: 10.1517/14712590902735795  0.47
Show low-probability matches.